Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The four-week intervals Each dose is held for four weeks before the next increase
The LEADER trial showed that Victoza reduced the risk of major cardiovascular events (cardiovascular death, nonfatal heart attack, or nonfatal stroke) by 13% compared to placebo in patients with type 2 diabetes and high cardiovascular risk
& Kwon, A
And shedding pounds may not be the only thing driving cardiovascular gains
Regional Leadership: North America dominates with 41% share, Europe follows with 28%, Asia-Pacific contributes 22%, Middle East & Africa hold 9%
US$ 29.54
US$ 24.47
US$ 25.32
US$ 29.78
US$ 23.87
US$ 22.63
US$ 27.27
US$ 21.60
US$ 27.14
